DrugPatentWatch Database Preview
VASOSTRICT Drug Profile
see a sample report or, see our see our flat-rate plans
When do Vasostrict patents expire, and when can generic versions of Vasostrict launch?
The generic ingredient in VASOSTRICT is vasopressin. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the vasopressin profile page.
Summary for VASOSTRICT
| US Patents: | 6 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 4 |
| Clinical Trials: | 1 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for VASOSTRICT |
| DailyMed Link: | VASOSTRICT at DailyMed |
Synonyms for VASOSTRICT
| 11034-16-5 |
| 12678-42-1 |
| 196116-EP2272972A1 |
| 196116-EP2272973A1 |
| 196116-EP2277872A1 |
| ADH (hormone) |
| AM012156 |
| EINECS 234-236-2 |
| HSDB 3412 |
| Intertocin |
| Inyectable de vasopresina [INN-Spanish] |
| Pitressin (TN) |
| Pituitrin |
| Pituitrin P |
| SCHEMBL1172390 |
| Solute injectable de vasopressine [INN-French] |
| Tonephin |
| UNII-Y87Y826H08 |
| Vasopressin (JP17/USP) |
| Vasopressin, unspecified |
| Vasopressina |
| Vasopressina [DCIT] |
| Vasopressine |
| Vasopressini injectio [INN-Latin] |
| Vasopressins |
| Vasopressinum |
| Y87Y826H08 |
US Patents and Regulatory Information for VASOSTRICT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Sterile Products | VASOSTRICT | vasopressin | SOLUTION;IV (INFUSION) | 204485-001 | Apr 17, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Par Sterile Products | VASOSTRICT | vasopressin | SOLUTION;IV (INFUSION) | 204485-002 | Dec 17, 2016 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Par Sterile Products | VASOSTRICT | vasopressin | SOLUTION;IV (INFUSION) | 204485-001 | Apr 17, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Par Sterile Products | VASOSTRICT | vasopressin | SOLUTION;IV (INFUSION) | 204485-002 | Dec 17, 2016 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
Paragraph IV (Patent) Challenges for VASOSTRICT
| Drugname | Dosage | Strength | RLD | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 20 units/mL, 1 mL | ➤ Subscribe | 2018-03-23 |
see a sample report or, see our see our flat-rate plans
